• Seeking Alpha

Nxera Pharma to Host R&D Day 2025

Seeking Alpha / 52 minutes from now 1 Views

Tokyo, Japan and Cambridge, UK, 4 November 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces that it will hold an R&D Day on 18 November 2025 at 17:00 JST.

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Flanders at the forefront of digital manufacturing: CNH completes Accelerator Project with Flanders Make and five partner companies at the Zedelgem plant
Next post
KBR Awarded Detailed Engineering Contract for Qatar’s High-Value Offshore Project

Comments

Just Posted

  • Standard Premium Finance Holdings to Highlight Growth Momentum and Strategic Outlook at 2025 Annual Shareholder Meeting

    4 hours from now

  • Worksport Releases Final COR System Specifications & Pricing

    4 hours from now

  • Mining Right Granted and Executed for Zeb Nickel

    4 hours from now

  • Reykjavíkurborg - kynningarfundur fyrir markaðsaðila vegna fjárhagsáætlunar

    4 hours from now

  • Novo Nordisk submits updated proposal to acquire Metsera, Inc.

    4 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1897

Categories

  • Seeking Alpha 1897

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts